Financials in USD. Standardized financial statements.
A compact view of how NEXT Biometrics Group ASA turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue? | $6.29M | $3.31M | $4.74M | $5.64M | $6.75M | $9.61M |
| Revenue Growth? | +89.9% | -30.2% | -15.9% | -16.4% | -29.8% | 0.0% |
| Cost of Revenue? | $2.85M | $7.11M | $7.57M | $10.03M | $11.56M | $15.57M |
| Gross Profit? | $85,448 | -$3.80M | -$2.82M | -$4.39M | -$4.81M | -$5.96M |
| Gross Margin? | +1.4% | -114.7% | -59.6% | -77.9% | -71.3% | -62.0% |
| Operating Expenses? | $4.29M | $2.85M | $2.28M | $3.50M | $6.49M | $12.64M |
| Operating Income? | -$4.05M | -$6.65M | -$5.11M | -$7.90M | -$11.30M | -$18.60M |
| EBITDA? | -$3.47M | -$5.73M | -$4.17M | -$5.67M | -$10.36M | -$16.71M |
| Income Before Tax | -$3.96M | -$6.43M | -$4.73M | -$6.61M | -$12.24M | -$18.70M |
| Income Tax Expense | $17,304 | $22,972 | -$6,218.95 | $183,477 | -$349,219 | $242,509 |
| Net Income? | -$3.97M | -$6.45M | -$4.72M | -$6.80M | -$11.89M | -$18.94M |
| EPS? | $-0.04 | $-0.07 | $-0.05 | $-0.08 | $-0.18 | $-0.42 |
| Diluted EPS? | $-0.04 | $-0.07 | $-0.05 | $-0.08 | $-0.18 | $-0.42 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality